BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38081505)

  • 1. Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer.
    Chen K; Ma Y; Zhong X; Lan J; Long D; Tian X; Yang Y; Yang Y
    Cancer Lett; 2024 Feb; 582():216586. PubMed ID: 38081505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
    Park JK; Jeong HO; Kim H; Choi JH; Lee EM; Kim S; Jang J; Choi DW; Lee SH; Kim KM; Jang KT; Lee KH; Lee KT; Lee MW; Lee JK; Lee S
    Mol Cancer; 2024 May; 23(1):87. PubMed ID: 38702773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma.
    Peng J; Sun BF; Chen CY; Zhou JY; Chen YS; Chen H; Liu L; Huang D; Jiang J; Cui GS; Yang Y; Wang W; Guo D; Dai M; Guo J; Zhang T; Liao Q; Liu Y; Zhao YL; Han DL; Zhao Y; Yang YG; Wu W
    Cell Res; 2019 Sep; 29(9):725-738. PubMed ID: 31273297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype.
    Juiz N; Elkaoutari A; Bigonnet M; Gayet O; Roques J; Nicolle R; Iovanna J; Dusetti N
    FASEB J; 2020 Sep; 34(9):12214-12228. PubMed ID: 32686876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
    Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
    Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development.
    Nelson SR; Zhang C; Roche S; O'Neill F; Swan N; Luo Y; Larkin A; Crown J; Walsh N
    Sci Rep; 2020 Feb; 10(1):2778. PubMed ID: 32066753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
    Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
    J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids.
    Palzer J; Mues B; Goerg R; Aberle M; Rensen SS; Olde Damink SWM; Vaes RDW; Cramer T; Schmitz-Rode T; Neumann UP; Slabu I; Roeth AA
    Int J Nanomedicine; 2021; 16():2965-2981. PubMed ID: 33935496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.
    Seino T; Kawasaki S; Shimokawa M; Tamagawa H; Toshimitsu K; Fujii M; Ohta Y; Matano M; Nanki K; Kawasaki K; Takahashi S; Sugimoto S; Iwasaki E; Takagi J; Itoi T; Kitago M; Kitagawa Y; Kanai T; Sato T
    Cell Stem Cell; 2018 Mar; 22(3):454-467.e6. PubMed ID: 29337182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 13. Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.
    Lee JJ; Bernard V; Semaan A; Monberg ME; Huang J; Stephens BM; Lin D; Rajapakshe KI; Weston BR; Bhutani MS; Haymaker CL; Bernatchez C; Taniguchi CM; Maitra A; Guerrero PA
    Clin Cancer Res; 2021 Nov; 27(21):5912-5921. PubMed ID: 34426439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma.
    Farshadi EA; Chang J; Sampadi B; Doukas M; Van 't Land F; van der Sijde F; Vietsch EE; Pothof J; Koerkamp BG; van Eijck CHJ
    Clin Cancer Res; 2021 Dec; 27(23):6602-6612. PubMed ID: 34580113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that enhance invasion.
    Jeong YJ; Knutsdottir H; Shojaeian F; Lerner MG; Wissler MF; Henriet E; Ng T; Datta S; Navarro-Serer B; Chianchiano P; Kinny-Köster B; Zimmerman JW; Stein-O'Brien G; Gaida MM; Eshleman JR; Lin MT; Fertig EJ; Ewald AJ; Bader JS; Wood LD
    J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36881486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system.
    Schuth S; Le Blanc S; Krieger TG; Jabs J; Schenk M; Giese NA; Büchler MW; Eils R; Conrad C; Strobel O
    J Exp Clin Cancer Res; 2022 Oct; 41(1):312. PubMed ID: 36273171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Organoids from pancreatic ductal adenocarcinoma].
    Dusetti N; Iovanna J
    Med Sci (Paris); 2020 Jan; 36(1):57-62. PubMed ID: 32014099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
    Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
    Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy.
    Gong M; Meng H; Tan D; Li P; Qin J; An Q; Shi C; An J
    Animal Model Exp Med; 2023 Oct; 6(5):409-418. PubMed ID: 37890865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens.
    Baker LA; Tiriac H; Tuveson DA
    Methods Mol Biol; 2019; 1882():97-115. PubMed ID: 30378047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.